We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and Eu... MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union. Show more
LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company...
- Company aligned with FDA on requirements for ongoing Phase 2 AQUAx2 clinical trial for Grade 2/3 radiation-induced xerostomia to be considered pivotal supporting potential BLA filing - Company...
LONDON and NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.08 | 1.62932790224 | 4.91 | 5.13 | 4.68 | 105924 | 4.8311746 | CS |
4 | -0.48 | -8.77513711152 | 5.47 | 5.9 | 4.68 | 142948 | 5.26203024 | CS |
12 | -1.54 | -23.5834609495 | 6.53 | 6.85 | 4.68 | 150200 | 5.86696742 | CS |
26 | 0.47 | 10.3982300885 | 4.52 | 7.6 | 4.32 | 211829 | 5.84091865 | CS |
52 | -0.32 | -6.0263653484 | 5.31 | 8.35 | 3.49 | 214857 | 5.61701431 | CS |
156 | -9.89 | -66.4650537634 | 14.88 | 24.8948 | 3.49 | 183744 | 9.95309681 | CS |
260 | -14.47 | -74.3576567318 | 19.46 | 30.23 | 3.49 | 166686 | 12.40331075 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions